Why You Should Shop Around for Car Insurance Right Now
If you haven’t shopped for auto insurance recently, you might want to spend an hour or so checking out other deals. It pays to review your policy and check what’s out there.
A new survey from insuranceQuotes.com shows that 66 percent of policyholders never or only rarely check to see if they could get the same or better coverage at a better price. The average American driver has been with the same auto insurance company for 12 years, and some have stayed with the same insurer for two to three decades, or longer.
Related: 5 Ways to Lower Your Car Insurance—Right Now
Millennials age 18 to 29 and senior citizens number among those least likely to shop around for auto insurance. At least six in 10 millennials with auto insurance assume you have to wait until your renewal date to switch insurance companies. And they’re not alone: 46 percent of Americans do not know that you can switch your auto insurance company at any time.
One of the reasons auto insurance may not be a priority for consumers? Auto pay options, while convenient, could be keeping car insurance payments and rates out of sight—and out of mind. Human nature and procrastination is another. “People think that it’s a task that might be difficult and time-consuming,” says senior analyst Laura Adams, “but it could be as simple as going to a website like insurancequotes.com, putting your information in for a free quote, and getting multiple quotes back. There’s no financial risk in looking for a new rate.”
Just spending an hour once a year to compare quotes from three different companies could potentially save you hundreds or thousands of dollars.
Related: A Quick Way to Save Big on Your Insurance
Experts suggest checking your car insurance rates the same way you would remember to change the oil in your car or swap the air filters in your home. Here are some tips to get started:
- Ask your current insurer if there are any company discounts you might be eligible for but don’t know about, such as the good-student discount. For college and grad students who have a B-average or better (or their parents) that could result in a significant discount.
- If you find a better deal, tell your current insurance company that you’re thinking of switching unless they can match the new offer or exceed it.
- If your current insurer refuses to negotiate, sign up for the new policy first—and then cancel the old one. “You always want to make sure you’re covered,” says Evans. “Insurance companies do not like to see a gap in coverage, and your rates could rise.”
- To get a wider variety of quotes, get online quotes from insurance company websites, consult with an independent agent, and look into companies that don’t use independent agents as well.
“Being married can cause your rate to decrease,” says Evan. “Marriage, getting good grades--these are all things that you have to self-report, which is why I recommend revisiting auto insurance at least once a year, as your life situation could change.”
Chart of the Day: High Deductible Blues
The higher the deductible in your health insurance plan, the less happy you probably are with it. That’s according to a new report on employer-sponsored health insurance from the Kaiser Family Foundation and the Los Angeles Times.
Chart of the Day: Tax Cuts and the Missing Capex Boom
Despite the Republican tax overhaul, businesses aren’t significantly increasing their capital expenditures. “The federal government will have to borrow an added $1 trillion through 2027 to pay for the corporate tax breaks,” says Bloomberg’s Mark Whitehouse. “So far, it’s hard to see what the country is getting in return.”
Chart of the Day: 2019’s Lobbying Leaders
Roll Call reports that trade, infrastructure and health care issues including prescription drug prices “dominated the lobbying agendas of some of the biggest spenders on K Street early this year.” Here’s Roll Call’s look at the top lobbying spenders so far this year:
Can You Fix Social Security? A New Tool Lets You Try
The Congressional Budget Office released an interactive tool Wednesday that shows how some widely discussed policy changes would affect the long-run financial health of the Social Security system.
“This interactive tool allows the user to explore seven policy options that could be used to improve the Social Security program’s finances and delay the trust funds’ exhaustion,” CBO said. “Four options would reduce benefits, and three options would increase payroll taxes. The tool allows for any combination of those options. It also lets the user change implementation dates and choose whether to show scheduled or payable benefits. … The tool also shows the impact of the options on different groups of people.”
Click here to view the interactive tool on the CBO website.
Why Prescription Drug Prices Keep Rising – and 3 Ways to Bring Them Down
Prescription drug prices have been rising at a blistering rate over the last few decades. Between 1980 and 2016, overall spending on prescription drugs rose from about $12 billion to roughly $330 billion, while its share of total health care spending doubled, from 5% to 10%.
Although lawmakers have shown renewed interest in addressing the problem, with pharmaceutical CEOs testifying before the Senate Finance Committee in February and pharmacy benefit managers (PBMS) scheduled to do so this week, no comprehensive plan to halt the relentless increase in prices has been proposed, let alone agreed upon.
Robin Feldman, a professor at the University of California Hastings College of Law, takes a look at the drug pricing system in a new book, “Drugs, Money and Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices.” In a recent conversation with Bloomberg’s Joe Nocera, Feldman said that one of the key drivers of rising prices is the ongoing effort of pharmaceutical companies to maintain control of the market.
Fearing competition from lower-cost generics, drugmakers began over the last 10 or 15 years to focus on innovations “outside of the lab,” Feldman said. These innovations include paying PBMs to reduce competition from generics; creating complex systems of rebates to PBMs, hospitals and doctors to maintain high prices; and gaming the patent system to extend monopoly pricing power.
Feldman’s research on the dynamics of the drug market led her to formulate three general solutions for the problem of ever-rising prices:
1) Transparency: The current system thrives on secret deals between drug companies and middlemen. Transparency “lets competitors figure out how to compete and it lets regulators see where the bad behaviors occur,” Feldman says.
2) Patent limitations: Drugmakers have become experts at extending patents on existing drugs, often by making minor modifications in formulation, dosage or delivery. Feldman says that 78% of drugs getting new patents are actually old drugs gaining another round of protection, and thus another round of production and pricing exclusivity. A “one-and-done” patent system would eliminate this increasingly common strategy.
3) Simplification: Feldman says that “complexity breeds opportunity,” and warns that the U.S. “drug price system is so complex that the gaming opportunities are endless.” While “ruthless simplification” of regulatory rules and approval systems could help eliminate some of those opportunities, Feldman says that the U.S. doesn’t seem to be moving in this direction.
Read the full interview at Bloomberg News.